Venn Biosciences Corporation
South San Francisco, CA
- UEI
- YP83K6AR81X3
- CAGE
- 854V2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2 Tower Pl #5, South San Francisco, CA 94080, USA
- Website
- intervenn.com
- Founded
- 2017
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Serum glycoproteomic signatures as early biomarkers for ovarian cancer | Defense Health Agency | $262,552 |
Quick answers
Is Venn Biosciences Corporation registered in SAM.gov?
Yes. Venn Biosciences Corporation's SAM.gov registration is active through July 22, 2027.
What is Venn Biosciences Corporation's most recent federal award?
Venn Biosciences Corporation's most recent federal grant award is Serum glycoproteomic signatures as early biomarkers for ovarian cancer (W81XWH2010414), from Defense Health Agency, on July 15, 2020.
On GovTribe
See Venn Biosciences Corporation's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors